Russia softens stance in foreign investor case, frees Frenchman
MOSCOW (Reuters) - Russia softened its stance in a high-profile legal standoff that has shaken foreign investors when a court on Thursday freed jailed French private equity executive Philippe Delpal from custody and placed him under house arrest instead. Delpal was one of several executives at private equity group Baring Vostok, including U.S. citizen Michael Calvey, who were detained in February on suspicion of embezzlement, an allegation they flatly deny.
MOSCOW (Reuters) - Russia softened its stance in a high-profile legal standoff that has shaken foreign investors when a court on Thursday freed jailed French private equity executive Philippe Delpal from custody and placed him under house arrest instead.
Delpal was one of several executives at private equity group Baring Vostok, including U.S. citizen Michael Calvey, who were detained in February on suspicion of embezzlement, an allegation they flatly deny.
They say the case against them is part of a vicious corporate dispute over control of a Russian bank.
Thursday's ruling comes days before President Vladimir Putin is due to travel to France next week to hold talks with President Emmanuel Macron, at which Delpal's fate is likely to be discussed.
The case against Baring Vostok has rattled Russia's business community and prompted several prominent officials and businessmen to voice concerns about the treatment of the executives.
Amid the outcry, Putin said in June that Delpal had not been released from house arrest earlier this year because he did not own property in Moscow.
The comments prompted Delpal's wife to buy an apartment, but the court had nonetheless decided to keep him in jail until now, according to media reports.
Russia's RDIF sovereign wealth fund welcomed the move to place Delpal under house arrest and said in a statement it hoped that the terms of custody for Russian executives being held would also be relaxed.
Calvey, who was moved from jail to house arrest in April, had hoped to win his full release at an appeal on Thursday, but the court ruled to keep him under house arrest.
(Reporting by Polina Ivanova, Katya Golubkova, Andrey Ostroukh, Maria Vasilyeva; Writing by Tom Balmforth; Editing by Andrew Osborn)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.